HALO
Halozyme Therapeutics, Inc.
HALO's outlook is improving, though it still trails on the overall score.
LLY
Eli Lilly and Company
LLY has the edge over HALO overall, supported by stronger fundamentals and stronger valuation.
HALO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Under pressure |
HALO's revenue, profitability and cash flow are currently healthy, but its balance sheet is under pressure.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
HALO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 10x | $101 | — |
| Cheap | 15x | $60.40 | -40% |
| Fair | 21x | $84.87 | -16% |
| Current | 25x | $101 | — |
| Expensive | 35x | $139 | +38% |
Historical ranges are pointers, not guarantees.
HALO has the edge over LLY in the historical PE scenario, which offers more potential upside but is not a forecast.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
HALO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for HALO, with profitability improving.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
HALO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.06 | +151% |
| Q3 2026 | $4.00 | -16% |
| Q2 2026 | $3.42 | -22% |
| Q1 2026 | $2.85 | -24% |
| Q4 2025 | $2.56 | -25% |
| Q3 2025 | $4.75 | +58% |
| Q2 2025 | $4.37 | +70% |
| Q1 2025 | $3.76 | +56% |
| Q4 2024 | $3.43 | +63% |
HALO earned $4.00 per share over the past year, down 16% from the year before.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over HALO on earnings, with more consistent year-over-year improvement.
HALO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $493M | +39% |
| Q2 2026 | $481M | +48% |
| Q1 2026 | $376.7M | +42% |
| Q4 2025 | $451.8M | +52% |
| Q3 2025 | $354.3M | +22% |
| Q2 2025 | $325.7M | +41% |
| Q1 2025 | $264.9M | +35% |
| Q4 2024 | $298M | +30% |
HALO's revenue has grown year over year for 19 quarters in a row: $493M last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 60% | -1.7 points |
| Q2 2026 | 60% | -2.4 points |
| Q1 2026 | 49% | -4.5 points |
| Q4 2025 | -21% | -80 points |
| Q3 2025 | 62% | +5.3 points |
| Q2 2025 | 62% | +12 points |
| Q1 2025 | 53% | +4.7 points |
| Q4 2024 | 59% | +15 points |
HALO has the edge over LLY on profitability, with a higher operating margin.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over HALO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
HALO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $255.2M | +45% |
| Q2 2026 | $236.7M | +141% |
| Q1 2026 | $176.3M | +15% |
| Q4 2025 | $217.6M | +24% |
| Q3 2025 | $175.6M | +54% |
| Q2 2025 | $98.1M | +84% |
| Q1 2025 | $153.3M | +22% |
| Q4 2024 | $175.4M | +76% |
HALO has the edge over LLY on cash flow, with more consistent year-over-year improvement.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY generated $19.7B in free cash flow over the past year, up 112% from the year before.
HALO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +1.4M shares |
| 1 year | +0.2% | +280K shares |
| 3 years | -8.6% | -11.5M shares |
| 5 years | -16% | -24.1M shares |
| Available history | -13% | -18.4M shares |
HALO has 123M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $67.3M |
| Q4 2025 | — |
| Q3 2025 | $38.9M |
| Q4 2024 | $250M |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | $252.3M |
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over HALO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
HALO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.2x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.5x | Elevated |
| Q4 2025 | 4.2x | High |
| Q3 2025 | 1.5x | Healthy |
| Q2 2025 | 2.1x | Moderate |
| Q1 2025 | 2.2x | Moderate |
| Q4 2024 | 2.5x | Moderate |
HALO's net debt is about 3.2 years of its operating earnings (EBITDA), up from 1.5 years a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY has the edge over HALO on leverage, with a lower net debt burden relative to earnings.
HALO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 47.7 | Neutral |
HALO's weekly RSI is 51 (neutral) and its Stochastic is 48 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
HALO PE vs Healthcare Sector
| Metric | HALO | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 26x | 2.6% below |
| PE % | 65 | 29 | 36 pts above |
HALO has the edge over LLY on valuation relative to its sector.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
HALO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $114.6 | 12% below |
| 20 week MA | $103.0 | 2.3% below |
| 50 week MA | $82.3 | 22% above |
| 100 week MA | $71.8 | 40% above |
| 200 week MA | $57.6 | 75% above |
HALO has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 75% above its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over HALO on trend strength, trading above more of its moving averages.
HALO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.0 | $42.9 | +139% |
| 2021 | $42.9 | $40.2 | -6.2% |
| 2022 | $40.2 | $57.5 | +43% |
| 2023 | $57.5 | $37.0 | -36% |
| 2024 | $37.0 | $48.1 | +30% |
| 2025 | $48.1 | $68.9 | +43% |
| 2026 YTD | $68.9 | $100.7 | +46% |
HALO has the edge over LLY on returns for 2026, with the stronger performance.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.